Balthaser Kevin
- SEC CIK
- 0001957554
No open-market purchases or sales filed in the past year.
Current role at each company
- ACRS Aclaris Therapeutics, Inc.Chief Financial Officeras of Mar 3, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Balthaser Kevin as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 7, 2023 (view filing) | Sep 6 | 1 day | Balthaser KevinChief Financial Officer | PPurchase | +9.49K | $7.90 | +$75.0K | +158.9%15.5K after | |
| Mar 3, 2023 (view filing) | Mar 2-3 | 1 day | Balthaser KevinChief Financial Officer | SSale | −1.89K | $12.45 | −$23.6K | −26.5%5.26K after | 2 lots |